Latest News & Features
Biotech
Three disputed sequencing patents took the spotlight as the Federal Circuit weighed challenges to a trio of PTAB rulings. 20 August 2026
Pharma
A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products. 20 August 2026
Pharma
Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach. 19 August 2026
MedTech
The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue. 18 August 2026
Careers
The new partner counts pharmaceuticals and life sciences among his specialisms and previously worked in-house at Sandoz. 18 August 2026
Careers
The IP advocacy group has turned to former USPTO acting director Coke Morgan Stewart as it enters what it calls a “new chapter”. 17 August 2026
Biotech
Europe’s biotechnology challenge is not only whether it can fund innovation. It is whether it can continue to originate and control the foundational IP positions from which future biotech value is created. Paul Calvo of Sterne Kessler explains. 17 August 2026
Pharma
Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection. 14 August 2026
MedTech
Clear aligner rivals are fighting over orthodontic technology across several major markets and the latest development in China has raised the stakes. 13 August 2026
Careers
Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech—in the US. 13 August 2026